Rare Epilepsy and Genomic Testing Explained with Dr. Erika Gray and Dr. Nancy Musarra

In this episode of the KCNA2 & Rare Epilepsy Podcast, Nancy sits down with Dr. Erika Gray, pharmacist and Chief Medical Officer of Toolbox Genomics, to break down the difference between genetics and genomics in a way families can actually understand. Together, they talk about how gene variants like KCNA2 can affect potassium channels, why gain-of-function and loss-of-function matter, how genomic testing may help guide treatment decisions, and what families should know about privacy, insurance, and next steps in testing. This is Part 1 of a two-part conversation focused on making a complex topic more clear, practical, and hopeful for families navigating rare epilepsy. Whether you are a parent, caregiver, clinician, or researcher, this episode offers an accessible introduction to how genomics may support more personalized care for children with rare epilepsies and other neurological conditions. Learn more: Toolbox Genomics: https://www.toolboxgenomics.com/ KCNA2 Epilepsy Foundation: https://www.kcna2epilepsy.org/